Generic Proair HFA: An Overview
Proair HFA® (
albuterol inhaler) is a prescription medication used to treat
asthma and other similar lung problems. It is part of a class of asthma drugs known as beta-adrenergic receptor agonists, or beta agonists for short.
Proair HFA is manufactured by Ivax Laboratories. It is currently under the protection of a patent that prevents any generic Proair HFA from being manufactured in the United States. Proair HFA is one of only a few environmentally friendly
albuterol inhalers. Older, "traditional" albuterol inhalers will no longer be available after December 31, 2008. None of the new inhalers have generic equivalents at this time.
When Will Generic Proair HFA Be Available?
The first patent for Proair HFA currently expires in November 2009. This is the earliest that a generic version of Proair HFA could become available. However, there are other circumstances that could arise to extend the exclusivity period of Proair HFA beyond 2009. These circumstances could include things such as other patents for specific
Proair HFA uses or lawsuits. Once Proair HFA goes off patent, there may be several companies that manufacture a generic Proair HFA drug.
The new albuterol inhalers are more expensive than the older versions, as no generics are available. There is currently a shortage of the older inhalers, which is expected to only get worse until they are no longer available (after December 31, 2008). People will need to switch to one of the new inhalers (such as Proair HFA), since albuterol is not a medication that one can "go without." If you have trouble affording the new inhalers, talk with your healthcare provider. There are programs available to help people who cannot afford the new inhalers.